STAR Act

Download PDF
Bill ID: 119/hr/9468
Last Updated: August 20, 2026

Sponsored by

Rep. Hern, Kevin [R-OK-1]

ID: H001082

Follow the money

The bill

STAR Act

HR. 9468, 119th Congress — read as touching Hospitals & Health Systems.

The sponsor

Rep. Hern, Kevin [R-OK-1]

Every bill has someone who introduced it. That name is where the paper trail starts.

The money

$82,105 raised

30 itemised contributions to this sponsor, pulled from FEC filings.

The alignment

85% match to Project 2025

This bill's text tracks the "Department of Health and Human Services" section, p. 497-499 of the Mandate for Leadership.

Bill's Journey to Becoming a Law

Track this bill's progress through the legislative process

Latest Action

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.

July 14, 2026

Introduced

📍 Current Status

Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.

🏛️

Committee Review

🗳️

Floor Action

✅

Passed House

🏛️

Senate Review

🎉

Passed Congress

🖊️

Presidential Action

⚖️

Became Law

📚 How does a bill become a law?

1. Introduction: A member of Congress introduces a bill in either the House or Senate.

2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.

3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.

4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.

5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.

6. Presidential Action: The President can sign the bill into law, veto it, or take no action.

7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!

Bill Summary

**HR 9468 – The STAR Act: A Prescription for Profit, Disguised as Policy**

**1. Main Purpose & Objectives** The STAR Act—*Saving Today’s Acute-Care Resources Act*—is not about saving resources. It’s about saving *money* for long-term care hospitals (LTCHs) by delaying and diluting Medicare payment reforms designed to curb overpayment. Its stated goal? Adjust LTCH payment rates under Medicare. The real goal? Let hospitals gaming the system keep cashing in for another six years, while taxpayers foot the bill for care that could be delivered cheaper—and just as effectively—in inpatient rehabilitation facilities or skilled nursing homes.

**2. Key Provisions & Changes to Existing Law** This bill surgically alters two critical provisions of the Social Security Act: - **Section 2(a)**: Extends the “site neutral payment reduction” delay from 2026 to **2032**. Site neutral payments were meant to end the ludicrous practice of paying LTCHs *more* than acute care hospitals for the same patient condition—because, apparently, a ventilator-dependent patient in a freestanding LTCH is worth 30% more than the same patient in a hospital ICU. Extending the delay means six more years of overpayment. - **Section 2(b)**: Introduces a new “high acuity criterion” to exempt even more LTCH discharges from site neutral payments. To qualify, a patient must: - Have been discharged from an acute or critical access hospital immediately prior, - Be assigned to an MS-LTC-DRG with a relative weight ≥0.8 (i.e., moderately severe, but not necessarily ventilator-dependent), - And be discharged from an LTCH that either: - Existed before enactment, - Had started construction/renovation (with ≥10% or $2.5M spent), - Or held a pre-enactment certificate of need (if state law requires it). - And the discharge must occur on or after October 1, 2026.

In plain English: they’ve carved out a loophole big enough to drive a medical convoy through—so hospitals that were already planning expansions can keep billing at inflated rates, provided they broke ground before the bill passed. Convenient timing, that.

**3. Affected Parties & Stakeholders** - **Winners**: LTCH operators (especially those with expansion plans), lobbyists who drafted this language, and investors in post-acute care real estate. - **Losers**: Medicare trustees, taxpayers, and patients who don’t need LTCH-level care but get funneled there because it’s more profitable. - **Bystanders**: Acute care hospitals, IRFs, and SNFs that compete unfairly against overpaid LTCHs. - **Enablers**: Congress members from Oklahoma, West Virginia, and Pennsylvania—coincidentally home to major LTCH chains—who somehow believe this is about “access to care,” not cash flow.

**4. Potential Impact & Implications** This is fiscal malpractice. By delaying site neutral payments and expanding exemptions, the STAR Act will cost Medicare **hundreds of millions—likely billions** over the next decade. It incentivizes inappropriate LTCH admissions, entrenches inefficient care delivery, and rewards hospitals for gaming regulatory loopholes rather than improving patient outcomes.

The bill’s title is a lie. It doesn’t save acute-care resources—it *wastes* them. It’s not reform; it’s rent-seeking with a congressional stamp of approval. If Medicare were a patient, this bill wouldn’t be a treatment—it’d be a self-inflicted wound, and Congress is the idiot insisting it’s just a flesh wound.

Diagnosis: Terminal stupidity, exacerbated by campaign contributions. Prognosis: Poor. Unless we stop electing the physicians who keep prescribing poison as medicine.

Related Topics

Healthcare & Insurance ReformResearch & Innovation Policy
Generated using Llama 3.1 70B (Dr. Haus personality)

💰 Campaign Finance Network

Rep. Hern, Kevin [R-OK-1]

Congress 119 • 2024 Election Cycle

Total Contributions
$82,105
25 donors
PACs
$3,000
Organizations
$35,700
Committees
$0
Individuals
$43,405
1
MORONGO BAND OF MISSION INDIANS
2 transactions
$3,000
1
CHICKASAW NATION
2 transactions
$6,600
2
CHEROKEE NATION
2 transactions
$5,000
3
OSAGE NATION
1 transaction
$3,300
4
UNITED KEETOOWAH BAND OF CHEROKEE INDIANS
1 transaction
$3,000
5
MUSCOGEE CREEK NATION
2 transactions
$3,000
6
SYCUAN BAND OF THE KYMEYAAY NATION
1 transaction
$2,500
7
SYCUAN BAN OF THE KUMEYAAY NATION
1 transaction
$2,500
8
MARSH POINTE MANAGEMENT LLC
1 transaction
$2,000
9
SHAKOPEE MDEWAKANTON
1 transaction
$1,650
10
SHAKOPEE MDEWAKANTON SIOUX COMMUNITY
1 transaction
$1,650
11
SANTA YNES BAND OF MISSION INDIANS
1 transaction
$1,500
12
DIEBOLT & SON INSURANCE PARTNERS LLC
1 transaction
$1,000
13
EMERALD NURSING & REHAB LANCASTER LLC
1 transaction
$1,000
14
EASTERN BAND OF CHEROKEE INDIANS
1 transaction
$1,000

No committee contributions found

1
BRUTON, BRENDA
2 transactions
$6,735
2
GASPAR, CLAY
1 transaction
$6,600
3
GIBBS, GEORGE E
1 transaction
$6,000
4
BLANTON, LORI
1 transaction
$4,000
5
ABBOTT, AARON
1 transaction
$3,435
6
HOM, MICHAEL
1 transaction
$3,435
7
BROWN JR, JAMES
1 transaction
$3,300
8
LATTNER, D.K.
1 transaction
$3,300
9
THOMAS, ROBERT
1 transaction
$3,300
10
THOMAS, WILLIAM
1 transaction
$3,300

Cosponsors & Their Campaign Finance

This bill has 4 cosponsors. Below are their top campaign contributors.

Rep. Miller, Carol D. [R-WV-1]

ID: M001205

Top Contributors

20

1
SCHUMACHER, AMANDA
SCHUMACHER AUTO • VICE PRESIDENT
IndividualWEST PALM BEACH, FL
$25,000
May 17, 2023
2
HALL, DANIEL
HALL STRATEGIES LLC • GOVERNMENT AFFAIRS CONSULTANT
IndividualBOLT, WV
$6,600
Mar 14, 2024
3
GONZALEZ, JULIO
GONZALEZ FAMILY OFFICE • FOUNDER/PRINCIPAL
IndividualLAKE WORTH BEACH, FL
$5,000
Jan 20, 2024
4
DUNCAN, ALEXANDER
IndividualCALDWELL, WV
$3,900
Aug 8, 2024
5
WAID, CHARLIE
CHARTER BROKERAGE LLC • CEO
IndividualKATY, TX
$3,409
May 12, 2024
6
LAMPTON, LESLIE III
ERGON INC. • OWNER/DIRECTOR
IndividualJACKSON, MS
$3,300
Nov 16, 2023
7
FARRELL, PATRICK MR.
SERVICE PUMP AND SUPPLY • OWNER/EXECUTIVE
IndividualHUNTINGTON, WV
$3,300
Dec 4, 2023
8
CHAN, ANNIE
KCR DEVELOPMENT • FOUNDER
IndividualHONOLULU, HI
$3,300
Dec 29, 2023
9
RICHARDS, WAYNE
GR ENERGY SERVICES • CEO
IndividualRICHMOND, TX
$3,300
Dec 29, 2023
10
MOSS, STEPHEN
APEX PIPELINE SERVICES INC. • PRESIDENT & CEO
IndividualLIBERTY, WV
$3,300
Feb 1, 2024

Rep. Smucker, Lloyd [R-PA-11]

ID: S001199

Top Contributors

20

1
MASRY, LOUIS
LEM SETTLEMENT GROUP • CEO-PRESIDENT
IndividualSOLANA BEACH, CA
$6,600
Jan 17, 2024
2
SCHWARZMAN, STEPHEN A.
BLACKSTONE • CEO AND CHAIRMAN
IndividualNEW YORK, NY
$6,600
Jul 13, 2023
3
SCHWARZMAN, CHRISTINE
NONE • RETIRED
IndividualNEW YORK, NY
$6,600
Jul 14, 2023
4
WALTERS, WILLIAM
SELECT MEDICAL • SVP
IndividualMCLEAN, VA
$5,000
Feb 5, 2024
5
REYNOLDS, GARY A.
RAYMOND JAMES FINANCIAL SERVICES • FINANCIAL ADVISOR
IndividualLANCASTER, PA
$4,597
Mar 27, 2024
6
PARKER, ALEXANDRA MRS.
SELF EMPLOYED • PHILANTHROPY
IndividualPALO ALTO, CA
$3,300
Mar 21, 2024
7
PARKER, ALEXANDRA MRS.
SELF EMPLOYED • PHILANTHROPY
IndividualPALO ALTO, CA
$3,300
Mar 21, 2024
8
PARKER, SEAN MR.
SEAN N. PARKER FOUNDATION • CHAIRMAN
IndividualPALO ALTO, CA
$3,300
Mar 21, 2024
9
PARKER, SEAN MR.
SEAN N. PARKER FOUNDATION • CHAIRMAN
IndividualPALO ALTO, CA
$3,300
Mar 21, 2024
10
MASRY, LOUIS
LEM SETTLEMENT GROUP • CEO-PRESIDENT
IndividualSOLANA BEACH, CA
$3,300
Jan 17, 2024

Rep. Kelly, Mike [R-PA-16]

ID: K000376

Top Contributors

30

1
SYCUAN BAND OF THE KUMEYAAY NATION
OrganizationEL CAJON, CA
$3,300
Dec 31, 2024
2
MASHANTUCKET PEQUOT TRIBE
OrganizationLEDYARD, CT
$3,300
Oct 23, 2023
3
MORONGO BAND OF MISSION INDIANS
OrganizationBANNING, CA
$3,300
Mar 24, 2023
4
MORONGO BAND OF MISSION INDIANS
OrganizationBANNING, CA
$3,300
Sep 30, 2024
5
SANTA YNEZ BAND OF MISSION INDIANS
OrganizationSANTA YNEZ, CA
$3,000
Sep 30, 2024
6
SANTA YNEZ BAND OF MISSION INDIANS
OrganizationSANTA YNEZ, CA
$3,000
Nov 4, 2024
7
SANTA YNEZ BAND OF MISSION INDIANS
OrganizationSANTA YNEZ, CA
$2,300
Jun 28, 2024
8
SANTA YNEZ BAND OF MISSION INDIANS
OrganizationSANTA YNEZ, CA
$2,000
Jun 26, 2023
9
SANTA YNEZ BAND OF MISSION INDIANS
OrganizationSANTA YNEZ, CA
$2,000
Oct 10, 2024
10
SALT RIVER PIMA MARICOPA INDIAN COMMUNITY
OrganizationSCOTTSDALE, AZ
$1,000
Mar 29, 2023

Rep. Carey, Mike [R-OH-15]

ID: C001126

Top Contributors

20

1
KITTLE, JEFFREY
KITTLE PROPERTY GROUP • CEO
IndividualINDIANAPOLIS, IN
$6,600
Oct 24, 2023
2
SCHWARZMAN, CHRISTINE
NONE • RETIRED
IndividualNEW YORK, NY
$6,600
Sep 28, 2023
3
SCHWARZMAN, STEPHEN
BLACKSTONE • CEO AND CHAIRMAN
IndividualNEW YORK, NY
$6,600
Sep 27, 2023
4
BAGAN, JOSEPH W.
STAQ PHARMA • CEO
IndividualCOLUMBUS, OH
$4,000
Oct 14, 2024
5
BAGAN, JOSEPH W.
IndividualCOLUMBUS, OH
$4,000
Oct 16, 2024
6
BORKOWSKI, BRIAN
HEARTLAND CHARGING SERVICES • COO
IndividualBELLEAIR BEACH, FL
$3,435
Oct 15, 2024
7
FISCHER, ALEX
SELF EMPLOYED • CONSULTING REAL ESTATE
IndividualCOLUMBUS, OH
$3,300
Oct 8, 2024
8
BARRERAS, LORI
STATE OF OHIO • COMMISSIONER, OCRC
IndividualCOLUMBUS, OH
$3,300
Nov 8, 2024
9
LAIRD, JAMES F.
DIAMOND HILL • EXECUTIVE
IndividualDUBLIN, OH
$3,300
Nov 5, 2024
10
RICHARDSON, JOHN G.
SUGARCREEK • CHAIRMAN
IndividualCINCINNATI, OH
$3,300
Dec 16, 2024

Donor Network - Rep. Hern, Kevin [R-OK-1]

PACs
Organizations
Individuals
Politicians

Hub layout: Politicians in center, donors arranged by type in rings around them.

Loading...

Showing 62 nodes and 67 connections

Total contributions: $67

Top Donors - Rep. Hern, Kevin [R-OK-1]

Showing top 25 donors by contribution amount

1 PAC14 Orgs10 Individuals

Industry Impact

Which industries are materially affected by specific provisions in this bill. 2 helped.

  • Section 2 extends site neutral payment reductions and modifies criteria for nonapplication of site neutral payment rate, which could increase Medicare payments to long-term care hospitals, thus benefiting the industry (SEC. 2. ADJUSTING LONG-TERM CARE HOSPITAL PAYMENT RATES UNDER THE MEDICARE PROGRAM).

  • The bill adjusts long-term care hospital payment rates under the Medicare program, which could lead to increased funding for long-term care facilities, thus benefiting the industry (SEC. 2. ADJUSTING LONG-TERM CARE HOSPITAL PAYMENT RATES UNDER THE MEDICARE PROGRAM).

Project 2025 Policy Matches

This bill shows semantic similarity to the following sections of the Project 2025 policy document.AI-enhanced analysis provides detailed alignment ratings.

Department of Health and Human Services

Strong
Vector: 64%
Pages: 497-499AI Enhanced

AI Analysis:

"The STAR Act aligns with Project 2025's goal of advancing site-neutral payment policies by extending and refining Medicare's site-neutral rate application to long-term care hospitals, aiming to reduce payment disparities based on care setting. While it includes a targeted exemption for high-acuity patients, the core mechanism supports Project 2025's objective of leveling the playing field among providers through site neutrality."

Key themes:site-neutral paymentsMedicare payment reformreducing setting-based payment disparitiesvalue-based care incentives

— 464 — Mandate for Leadership: The Conservative Promise l The Risk Adjustment Data Validation (RADV) rule; l The Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI) demonstration; and l The Global and Professional Direct Contracting (GPDC, rebranded as the Accountable Care Organization Realizing Equity, Access, and Community Health or ACO REACH) model. Additionally, regulations should advance site neutrality by eliminating the inpa- tient-only list and expanding the ambulatory surgical center covered procedures list. Medicare generally pays more for inpatient hospital procedures and less for the same procedures performed in an outpatient setting. Whether a medical ser- vice is delivered in a physician’s office, a clinic, or a hospital setting, the Medicare payment for that service should be the same. CMS should expand the application of site-neutral payment options to more settings. Such a policy would level the playing field among providers and remove the financial disabilities for medical professionals who would compete with hospital systems.23 Finally, HHS needs to restore and enhance conscience protection regulations that allow medical practitioners to participate in federal health care programs without being compelled to provide sex changes or similar services. LEGISLATIVE PROPOSALS l Remove restrictions on physician-owned hospitals. The Affordable Care Act (ACA)24 imposed restrictions prohibiting Medicare from reimbursing physician-owned and specialty hospitals. The current restrictions do little more than serve the special interests of large hospital systems and undercut consumer choice of high-quality, specialty care. These restrictions should be removed so that physician-owned hospitals can compete with other hospitals in serving Medicare patients.25 l Encourage more direct competition between Medicare Advantage and private plans. Medicare Advantage (MA), a system of competing private health plans, is the major alternative to traditional Medicare for America’s large and growing cohort of seniors. The program provides beneficiaries with a wide range of competitive health plan choices—a richer set of benefits than traditional Medicare provides and at a reasonable cost. Equally as important, the MA program has been registering consistently high marks for superior performance in delivering high-quality care. Critical reforms are still needed to strengthen and improve the program for the future. Specifically: — 465 — Department of Health and Human Services 1. Make Medicare Advantage the default enrollment option. 2. Give beneficiaries direct control of how they spend Medicare dollars. 3. Remove burdensome policies that micromanage MA plans. 4. Replace the complex formula-based payment model with a competitive bidding model. 5. Reconfigure the current risk adjustment model. 6. Remove restrictions on key benefits and services, including those related to prescription drugs, hospice care, and medical savings account plans.26 Legacy Medicare Reform. Legislation reforming legacy (non-MA) Medicare should: l Base payments on the health status of the patient or intensity of the service rather than where the patient happens to receive that service. l Replace the bureaucrat-driven fee-for-service system with value- based payments to empower patients to find the care that best serves their needs. l Codify price transparency regulations. l Restructure 340B drug subsidies27 toward beneficiaries rather than hospitals. l Repeal harmful health policies enacted under the Obama and Biden Administrations such as the Medicare Shared Savings Program28 and Inflation Reduction Act.29 Medicare Part D Reform. The Inflation Reduction Act (IRA) created a drug price negotiation program in Medicare that replaced the existing private-sector negotiations in Part D with government price controls for prescription drugs. These government price controls will limit access to medications and reduce patient access to new medication. This “negotiation” program should be repealed, and reforms in Part D that will have meaningful impact for seniors should be pursued. Other reforms should include eliminating the coverage gap in Part D, reducing the government share in

Department of Health and Human Services

Strong
Vector: 61%
Pages: 497-499AI Enhanced

AI Analysis:

"The STAR Act aligns with Project 2025's objective to advance site-neutral payment policies by extending and refining Medicare's site-neutral payment reductions for long-term care hospitals, which supports leveling payment across care settings and reducing disparities between inpatient and outpatient services."

Key themes:site-neutral paymentsMedicare payment reformcare setting paritycost containment in healthcare

— 464 — Mandate for Leadership: The Conservative Promise l The Risk Adjustment Data Validation (RADV) rule; l The Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI) demonstration; and l The Global and Professional Direct Contracting (GPDC, rebranded as the Accountable Care Organization Realizing Equity, Access, and Community Health or ACO REACH) model. Additionally, regulations should advance site neutrality by eliminating the inpa- tient-only list and expanding the ambulatory surgical center covered procedures list. Medicare generally pays more for inpatient hospital procedures and less for the same procedures performed in an outpatient setting. Whether a medical ser- vice is delivered in a physician’s office, a clinic, or a hospital setting, the Medicare payment for that service should be the same. CMS should expand the application of site-neutral payment options to more settings. Such a policy would level the playing field among providers and remove the financial disabilities for medical professionals who would compete with hospital systems.23 Finally, HHS needs to restore and enhance conscience protection regulations that allow medical practitioners to participate in federal health care programs without being compelled to provide sex changes or similar services. LEGISLATIVE PROPOSALS l Remove restrictions on physician-owned hospitals. The Affordable Care Act (ACA)24 imposed restrictions prohibiting Medicare from reimbursing physician-owned and specialty hospitals. The current restrictions do little more than serve the special interests of large hospital systems and undercut consumer choice of high-quality, specialty care. These restrictions should be removed so that physician-owned hospitals can compete with other hospitals in serving Medicare patients.25 l Encourage more direct competition between Medicare Advantage and private plans. Medicare Advantage (MA), a system of competing private health plans, is the major alternative to traditional Medicare for America’s large and growing cohort of seniors. The program provides beneficiaries with a wide range of competitive health plan choices—a richer set of benefits than traditional Medicare provides and at a reasonable cost. Equally as important, the MA program has been registering consistently high marks for superior performance in delivering high-quality care. Critical reforms are still needed to strengthen and improve the program for the future. Specifically:

Department of Health and Human Services

Moderate
Vector: 61%
Pages: 530-532AI Enhanced

AI Analysis:

"The STAR Act aligns moderately with Project 2025's HHS objectives by aiming to control Medicare spending through payment reforms while preserving access to care for high-acuity patients, reflecting a balance between fiscal responsibility and healthcare access. However, it does not explicitly address underserved communities or equity-focused goals emphasized in the HHS Strategic Plan cited in Project 2025."

Key themes:Medicare spending reformhealthcare accesspayment policylong-term care hospitalsfiscal responsibility in healthcare

— 498 — Mandate for Leadership: The Conservative Promise ENDNOTES 1. U.S. Department of Health and Human Services, Strategic Plan, FY 2018–2022, p. 50, https://aspe.hhs.gov/ sites/default/files/documents/feac346aca967bfadc446398679e14ec/hhs-strategic-plan-fy-2018-2022.pdf (accessed February 7, 2023). 2. “Strategic Goal 1: Protect and Strengthen Equitable Access to High Quality and Affordable Healthcare” in ibid. “In the context of HHS, this Strategic Plan adopts the definition of underserved communities listed in Executive Order 13985: Advancing Racial Equity and Support for Underserved Communities through the Federal Government to refer to ‘populations sharing a particular characteristic, as well as geographic communities, who have been systematically denied a full opportunity to participate in aspects of economic, social, and civic life’; this definition includes individuals who belong to underserved communities that have been denied such treatment, such as Black, Latino, and Indigenous and Native American persons, Asian Americans and Pacific Islanders and other persons of color; members of religious minorities; lesbian, gay, bisexual, transgender, and queer (LGBTQ+) persons; persons with disabilities; persons who live in rural areas; and persons otherwise adversely affected by persistent poverty or inequality. Individuals may belong to more than one underserved community and face intersecting barriers. This definition applies to the terms underserved communities and underserved populations throughout this Strategic Plan.” Ibid. Emphasis in original. 3. Karen Weintraub, “Americans’ Life Expectancy Continues to Fall, Erasing Health Gains of the Last Quarter Century,” USA Today, December 22, 2022, https://www.usatoday.com/story/news/health/2022/12/22/us-life- expectancy-continues-fall-erasing-25-years-health-gains/10937418002/ (accessed February 6, 2023). 4. Apoorva Mandavilli, “The C.D.C. Isn’t Publishing Large Portions of the Data It Collects,” The New York Times, updated February 22, 2022, https://www.congress.gov/117/meeting/house/114450/documents/HHRG-117- IF02-20220302-SD004.pdf (accessed March 22, 2023). 5. Zachary B. Sluzala and Edmund F. Haislmaier, “Lessons from COVID-19: How Policymakers Should Reform the Regulation of Clinical Testing,” Heritage Foundation Backgrounder No. 3696, March 28, 2022, https://www. heritage.org/public-health/report/lessons-covid-19-how-policymakers-should-reform-the-regulation-clinical. 6. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, “Centers for Disease Control and Prevention (C),” https://www.cdc.gov/maso/pdf/cdcmiss.pdf (March 16, 2023). 7. Judith Garber, “CDC ‘Disclaimers’ Hide Financial Conflicts of Interest,” Lown Institute Accountability Blog, November 6, 2019, https://lowninstitute.org/cdc-disclaimers-hide-financial-conflicts-of-interest/ (accessed February 6, 2023). See also U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, “CDC Foundation Active Programs (October 1, 2014–September 30, 2015),” https://www. cdcfoundation.org/sites/default/files/upload/pdf/CDCFoundation-ActivePrograms-FY2015.pdf (accessed February 7, 2023); “CDC Active Programs (October 1, 2015–September 30, 2016),” https://www.cdcfoundation. org/sites/default/files/upload/pdf/CDCFoundation-ActivePrograms-FY2016.pdf (accessed February 7, 2023); “CDC Foundation Active Programs (October 1, 2016–September 30, 2017),” https://www.cdcfoundation.org/ sites/default/files/upload/pdf/CDCFoundation-ActivePrograms-FY2017.pdf (accessed February 7, 2023); “CDC Foundation Active Programs (October 1, 2017–September 30, 2018),” https://www.cdcfoundation.org/sites/default/ files/upload/pdf/CDCFoundation-ActivePrograms-FY2018.pdf (accessed February 7, 2023); “CDC Foundation Active Programs, October 1, 2018–September 30, 2019,” https://www.cdcfoundation.org/sites/default/files/upload/ pdf/CDCFoundation-ActivePrograms-FY2019.pdf (accessed February 7, 2023); “CDC Foundation Active Programs, October 1, 2029–September 30, 2020,” https://www.cdcfoundation.org/CDCF-ActivePrograms-CDC-FY20?inline (accessed February 7, 2023); and “CDC Foundation Active Programs, October 1, 2020–September 30, 2021,” https://www.cdcfoundation.org/CDCF-ActivePrograms-CDC-FY21?inline (accessed February 7, 2023). 8. Joel White and Doug Badger, “In Order to Defeat COVID-19, the Federal Government Must Modernize Its Public Health Data,” Heritage Foundation Backgrounder No. 3527, September 3, 2020, https://www.heritage. org/sites/default/files/2020-09/BG3527_0.pdf. 9. S. 15, Ensuring Accurate and Complete Abortion Data Reporting Act of 2023, 118th Congress, introduced January 23, 2023, https://www.congress.gov/118/bills/s15/BILLS-118s15is.pdf (accessed March 22, 2023), and H.R. 632, Ensuring Accurate and Complete Abortion Data Reporting Act of 2023, 118th Congress, introduced January 30, 2023, https://www.congress.gov/118/bills/hr632/BILLS-118hr632ih.pdf (accessed March 22, 2023). 10. Doug Badger, “How Congress Can Make Real Progress on Drug Prices,” Heritage Foundation Issue Brief No. 5016, December 9, 2019, https://www.heritage.org/sites/default/files/2019-12/IB5016_1.pdf. — 499 — Department of Health and Human Services 11. Sluzala and Haislmaier, “Lessons From COVID-19: How Policymakers Should Reform the Regulation of Clinical Testing.” 12. Ibid. 13. H.R. 5471, Clinical Laboratory Improvement Amendments of 1988, Public Law No. 100-578, 100th Congress, October 31, 1988, https://uscode.house.gov/statutes/pl/100/578.pdf (accessed March 17, 2023). 14. Sluzala and Haislmaier, “Lessons From COVID-19: How Policymakers Should Reform the Regulation of Clinical Testing.” 15. Edmund F. Haislmaier, “Ensuring Americans’ Access to Pharmaceuticals: A Primer and Road Map for Policymakers,” Heritage Foundation Backgrounder No. 3545, October 20, 2020, https://www.heritage.org/ sites/default/files/2020-10/BG3545.pdf. 16. 18 U.S.C. 1461, https://www.law.cornell.edu/uscode/text/18/1461 (accessed March 16, 2023), and 18 U.S.C. 1462, https://www.law.cornell.edu/uscode/text/18/1462 (accessed March 16, 2023). 17. H.R. 1308, Religious Freedom Restoration Act of 1993, Public Law No. 103-141, 103rd Congress, November 16, 1993, https://www.congress.gov/103/statute/STATUTE-107/STATUTE-107-Pg1488.pdf (accessed March 18, 2023). 18. Charles Piller, “Is FDA’s Revolving Door Open Too Wide?” Science, Vol. 361, No. 6397 (July 6, 2018), p. 21, https://www.science.org/doi/epdf/10.1126/science.361.6397.21 (accessed February 6, 2023). 19. Joel Achenbach, “NIH Halts $100 Million Study of Moderate Drinking That Is Funded by Alcohol Industry,” The Washington Post, May 17, 2018, https://www.washingtonpost.com/news/to-your-health/wp/2018/05/17/nih- halts-controversial-study-of-moderate-drinking/ (accessed February 6, 2023). 20. Alexander Tin, “Moderna Offers NIH Co-ownership of COVID Vaccine Patent amid Dispute with Government,” CBS News, November 15, 2021, https://www.cbsnews.com/news/moderna-covid-vaccine-patent-dispute- national-institutes-health/ (accessed February 6, 2023). 21. Informed Consent Action Network, “NIH Officials Profiting from COVID-19 Vaccine,” June 3, 2021, https://www. icandecide.org/nih-officials-profiting-from-covid-19-vaccine/ (accessed February 6, 2023). 22. Adam Andrzejewski, “Substack Investigation: Fauci’s Royalties and the $350 Million Royalty Payment Stream HIDDEN by NIH,” Open the Books Substack, May 9, 2022, https://openthebooks.substack. com/p/faucis-royalties-and-the-350-million?utm_source=/profile/24758236-adam-andrzejewski&utm_ medium=reader2&s=w (accessed February 6, 2023). 23. Robert E. Moffit, “Time to Reverse Hospital Market Consolidation,” Heritage Foundation Commentary, January 5, 2022, https://www.heritage.org/health-care-reform/commentary/time-reverse-hospital-market-consolidation. 24. H.R. 3590, Patient Protection and Affordable Care Act, Public Law No. 111-148, 111th Congress, March 23, 2021, https://www.congress.gov/111/plaws/publ148/PLAW-111publ148.pdf (accessed March 16, 2023). 25. Brian J. Miller, Robert E. Moffit, James Ficke, Joseph Marine, and Jesse Ehrenfeld, “Reversing Hospital Consolidation: The Promise of Physician-Owned Hospitals,” Health Affairs Forefront, April 12, 2021, https:// www.healthaffairs.org/do/10.1377/forefront.20210408.980640/ (accessed February 13, 2023). 26. Robert E. Moffit, “Medicare’s Future: Challenges and Opportunities,” testimony before the Special Committee on Aging, U.S. Senate, November 21, 2022, https://www.heritage.org/testimony/medicares-future-challenges- and-opportunities. 27. 42 U.S. Code § 256b, https://www.law.cornell.edu/uscode/text/42/256b (accessed March 16, 2023). 28. H.R. 3590, Patient Protection and Affordable Care Act, § 3022. 29. H.R. 5376, Inflation Reduction Act of 2022, Public Law No. 117-169, 117th Congress, August 16, 2022, https:// www.congress.gov/117/plaws/publ169/PLAW-117publ169.pdf (accessed March 16, 2023). 30. Robert E. Moffit, “Reducing Patient Access to New Medications Is the Left’s Latest Medicare Price-Fixing Scheme,” Heritage Foundation Commentary, July 22, 2022, https://www.heritage.org/medicare/commentary/ reducing-patient-access-new-medications-the-lefts-latest-medicare-price-fixing, and Badger, “How Congress Can Make Real Progress on Drug Prices.” 31. Nina Owcharenko Schaefer, “Medicaid at 55: Understanding the Design, Trends, and Reforms Needed to Improve the Health Care Safety Net,” Heritage Foundation Backgrounder No. 3604, April 14, 2021, https:// www.heritage.org/sites/default/files/2021-04/BG3604_0.pdf, and Brian C. Blase, “Punishing Conservative States: Payment Cuts to Hospitals Where Federal Spending Is Already Low,” Paragon Health Institute, December 2021, https://paragoninstitute.org/wp-content/uploads/2022/06/Punishing-Conservative-States- HTML.html (accessed February 13, 2023).

Showing 3 of 5 policy matches

About These Correlations

Policy matches are calculated using a hybrid approach: initial candidates are found using semantic similarity between bill summaries and Project 2025 policy text, then an AI model (Llama 3.1 70B) provides detailed alignment ratings and analysis. Ratings range from 1 (minimal alignment) to 5 (very strong alignment). This analysis does not imply direct causation or intent.

Full Policy Text

Related Bills